Global Congenital Heart Diseases Market Report 2018 - Industry Analysis, Size, Share, production and Forecasts to 2025

 Buy Now

   Published Date : Sep-2018   |    Format : PDF   |    Pages : 98
This report focuses on the global Congenital Heart Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Congenital Heart Diseases development in United States, Europe and China.

Congenital diseases are disorders in a newborn due to certain genetic factors (and sometimes in association with the environment) that often results in malformations or underdeveloped organs. Congenital Heart Diseases (CHD) results in malformed or undeveloped heart that presents in a newborn with breathing and circulation disorders. According to Lancet medical journal, CHD caused death of 0.22 million individuals and newborns globally in the year 2010. CHD was earlier erroneously associated with premature births, the association has no direct correlation with all forms of CHD and is mainly one of the many factors that can cause it. The genetic factors causing CHD consist of chromosomal errors in fertilization and the following meiotic division, these include: large chromosomal defects in trisomal chromosomes; small chromosomal defects like microdeletion of long/short arm of chromosome and random/environmentally induced mutation of heart muscle cell proteins, or associated proteins etc. The environmental factors like rubella infections, thalidomide drugs, metals (lithium, lead, mercury, etc), chronic illness in the mother (systemic lupus, diabetes, phenylketonuria, etc). Embryological changes, hormonal changes in the mother and certain birth deficiencies can also cause CHD and other birth defects in children. Besides these, according to some medical research reports, maternal obesity increased the chances of CHD in newborns; obesity was shown to increase the risk of previously hidden genetic traits of CHD in the new born children of such obese mothers.
The treatment of CHD varies from case to case; genetic testing/screening is mandatory in case the doctor suspects a genetic cause for the disease, in developed countries this is done for all newborns. The next step would be surgery or drug treatment, again this depends upon the severity of the condition. In most cases CHD presents itself as serious conditions with high risk of complications, hence surgery is the most followed procedure. In certain disorders like ASD a pediatric surgeon may ask the parents of a CHD child to wait for the child’s growth as ASD is known to disappear gradually, a surgery is performed if ASD persists after the child’s growth. Certain cases also require multiple surgeries and stenting in order to restore a malformed tract in the lungs, etc. Drugs like diuretics are given to regulate vasoconstriction that alleviates deoxygenation and helps remove toxins from the body, besides reducing the heartbeat.
In 2017, the global Congenital Heart Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
    Pfizer
    Abbott Laboratories
    Eli Lilly
    Ranbaxy Pharmaceutical
    ...

Market segment by Type, the product can be split into
    Hypoplasia
    Obstructive
    Septal Defects

Market segment by Application, split into
    Hospitals
    Ambulatory Surgical Centers
    Diagnostic Centers
    Others

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Congenital Heart Diseases status, future forecast, growth opportunity, key market and key players.
    To present the Congenital Heart Diseases development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Congenital Heart Diseases are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Congenital Heart Diseases Market Size Growth Rate by Type (2013-2025)
        1.4.2 Hypoplasia
        1.4.3 Obstructive
        1.4.4 Septal Defects
    1.5 Market by Application
        1.5.1 Global Congenital Heart Diseases Market Share by Application (2013-2025)
        1.5.2 Hospitals
        1.5.3 Ambulatory Surgical Centers
        1.5.4 Diagnostic Centers
        1.5.5 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Congenital Heart Diseases Market Size
    2.2 Congenital Heart Diseases Growth Trends by Regions
        2.2.1 Congenital Heart Diseases Market Size by Regions (2013-2025)
        2.2.2 Congenital Heart Diseases Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Congenital Heart Diseases Market Size by Manufacturers
        3.1.1 Global Congenital Heart Diseases Revenue by Manufacturers (2013-2018)
        3.1.2 Global Congenital Heart Diseases Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Congenital Heart Diseases Market Concentration Ratio (CR5 and HHI)
    3.2 Congenital Heart Diseases Key Players Head office and Area Served
    3.3 Key Players Congenital Heart Diseases Product/Solution/Service
    3.4 Date of Enter into Congenital Heart Diseases Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Congenital Heart Diseases Market Size by Type (2013-2018)
    4.2 Global Congenital Heart Diseases Market Size by Application (2013-2018)

5 United States
    5.1 United States Congenital Heart Diseases Market Size (2013-2018)
    5.2 Congenital Heart Diseases Key Players in United States
    5.3 United States Congenital Heart Diseases Market Size by Type
    5.4 United States Congenital Heart Diseases Market Size by Application

6 Europe
    6.1 Europe Congenital Heart Diseases Market Size (2013-2018)
    6.2 Congenital Heart Diseases Key Players in Europe
    6.3 Europe Congenital Heart Diseases Market Size by Type
    6.4 Europe Congenital Heart Diseases Market Size by Application

7 China
    7.1 China Congenital Heart Diseases Market Size (2013-2018)
    7.2 Congenital Heart Diseases Key Players in China
    7.3 China Congenital Heart Diseases Market Size by Type
    7.4 China Congenital Heart Diseases Market Size by Application

8 Japan
    8.1 Japan Congenital Heart Diseases Market Size (2013-2018)
    8.2 Congenital Heart Diseases Key Players in Japan
    8.3 Japan Congenital Heart Diseases Market Size by Type
    8.4 Japan Congenital Heart Diseases Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Congenital Heart Diseases Market Size (2013-2018)
    9.2 Congenital Heart Diseases Key Players in Southeast Asia
    9.3 Southeast Asia Congenital Heart Diseases Market Size by Type
    9.4 Southeast Asia Congenital Heart Diseases Market Size by Application

10 India
    10.1 India Congenital Heart Diseases Market Size (2013-2018)
    10.2 Congenital Heart Diseases Key Players in India
    10.3 India Congenital Heart Diseases Market Size by Type
    10.4 India Congenital Heart Diseases Market Size by Application

11 Central & South America
    11.1 Central & South America Congenital Heart Diseases Market Size (2013-2018)
    11.2 Congenital Heart Diseases Key Players in Central & South America
    11.3 Central & South America Congenital Heart Diseases Market Size by Type
    11.4 Central & South America Congenital Heart Diseases Market Size by Application

12 International Players Profiles
    12.1 Pfizer
        12.1.1 Pfizer Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Congenital Heart Diseases Introduction
        12.1.4 Pfizer Revenue in Congenital Heart Diseases Business (2013-2018)
        12.1.5 Pfizer Recent Development
    12.2 Abbott Laboratories
        12.2.1 Abbott Laboratories Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Congenital Heart Diseases Introduction
        12.2.4 Abbott Laboratories Revenue in Congenital Heart Diseases Business (2013-2018)
        12.2.5 Abbott Laboratories Recent Development
    12.3 Eli Lilly
        12.3.1 Eli Lilly Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Congenital Heart Diseases Introduction
        12.3.4 Eli Lilly Revenue in Congenital Heart Diseases Business (2013-2018)
        12.3.5 Eli Lilly Recent Development
    12.4 Ranbaxy Pharmaceutical
        12.4.1 Ranbaxy Pharmaceutical Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Congenital Heart Diseases Introduction
        12.4.4 Ranbaxy Pharmaceutical Revenue in Congenital Heart Diseases Business (2013-2018)
        12.4.5 Ranbaxy Pharmaceutical Recent Development

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details



List of Tables and Figures

    Table Congenital Heart Diseases Key Market Segments
    Table Key Players Congenital Heart Diseases Covered
    Table Global Congenital Heart Diseases Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Congenital Heart Diseases Market Size Market Share by Type 2013-2025
    Figure Hypoplasia Figures
    Table Key Players of Hypoplasia
    Figure Obstructive Figures
    Table Key Players of Obstructive
    Figure Septal Defects Figures
    Table Key Players of Septal Defects
    Table Global Congenital Heart Diseases Market Size Growth by Application 2013-2025 (Million US$)
    Figure Hospitals Case Studies
    Figure Ambulatory Surgical Centers Case Studies
    Figure Diagnostic Centers Case Studies
    Figure Others Case Studies
    Figure Congenital Heart Diseases Report Years Considered
    Table Global Congenital Heart Diseases Market Size 2013-2025 (Million US$)
    Figure Global Congenital Heart Diseases Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Congenital Heart Diseases Market Size by Regions 2013-2025 (Million US$)
    Table Global Congenital Heart Diseases Market Size by Regions 2013-2018 (Million US$)
    Table Global Congenital Heart Diseases Market Share by Regions 2013-2018
    Figure Global Congenital Heart Diseases Market Share by Regions 2013-2018
    Figure Global Congenital Heart Diseases Market Share by Regions 2018
    Table Market Top Trends
    Table Global Congenital Heart Diseases Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Congenital Heart Diseases Market Share by Manufacturers (2013-2018)
    Figure Global Congenital Heart Diseases Market Share by Manufacturers in 2018
    Table Global Congenital Heart Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Congenital Heart Diseases Product/Solution/Service
    Table Date of Enter into Congenital Heart Diseases Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Congenital Heart Diseases Market Size by Type (2013-2018) (Million US$)
    Table Global Congenital Heart Diseases Market Size Share by Type (2013-2018)
    Figure Global Congenital Heart Diseases Market Size Market Share by Type (2013-2018)
    Table Global Congenital Heart Diseases Market Size by Application (2013-2018) (Million US$)
    Table Global Congenital Heart Diseases Market Size Share by Application (2013-2018)
    Figure Global Congenital Heart Diseases Market Size Market Share by Application (2013-2018)
    Figure Global Congenital Heart Diseases Revenue Market Share by Application in 2017
    Figure United States Congenital Heart Diseases Market Size 2013-2018 (Million US$)
    Table United States Key Players Congenital Heart Diseases Revenue (2017-2018) (Million US$)
    Table United States Key Players Congenital Heart Diseases Market Share (2017-2018)
    Table United States Congenital Heart Diseases Market Size by Type (2013-2018) (Million US$)
    Table United States Congenital Heart Diseases Market Share by Type (2013-2018)
    Table United States Congenital Heart Diseases Market Size by Application (2013-2018) (Million US$)
    Table United States Congenital Heart Diseases Market Share by Application (2013-2018)
    Figure Europe Congenital Heart Diseases Market Size 2013-2018 (Million US$)
    Table Europe Key Players Congenital Heart Diseases Revenue (2017-2018) (Million US$)
    Table Europe Key Players Congenital Heart Diseases Market Share (2017-2018)
    Table Europe Congenital Heart Diseases Market Size by Type (2013-2018) (Million US$)
    Table Europe Congenital Heart Diseases Market Share by Type (2013-2018)
    Table Europe Congenital Heart Diseases Market Size by Application (2013-2018) (Million US$)
    Table Europe Congenital Heart Diseases Market Share by Application (2013-2018)
    Figure China Congenital Heart Diseases Market Size 2013-2018 (Million US$)
    Table China Key Players Congenital Heart Diseases Revenue (2017-2018) (Million US$)
    Table China Key Players Congenital Heart Diseases Market Share (2017-2018)
    Table China Congenital Heart Diseases Market Size by Type (2013-2018) (Million US$)
    Table China Congenital Heart Diseases Market Share by Type (2013-2018)
    Table China Congenital Heart Diseases Market Size by Application (2013-2018) (Million US$)
    Table China Congenital Heart Diseases Market Share by Application (2013-2018)
    Figure Japan Congenital Heart Diseases Market Size 2013-2018 (Million US$)
    Table Japan Key Players Congenital Heart Diseases Revenue (2017-2018) (Million US$)
    Table Japan Key Players Congenital Heart Diseases Market Share (2017-2018)
    Table Japan Congenital Heart Diseases Market Size by Type (2013-2018) (Million US$)
    Table Japan Congenital Heart Diseases Market Share by Type (2013-2018)
    Table Japan Congenital Heart Diseases Market Size by Application (2013-2018) (Million US$)
    Table Japan Congenital Heart Diseases Market Share by Application (2013-2018)
    Figure Southeast Asia Congenital Heart Diseases Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Congenital Heart Diseases Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Congenital Heart Diseases Market Share (2017-2018)
    Table Southeast Asia Congenital Heart Diseases Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Congenital Heart Diseases Market Share by Type (2013-2018)
    Table Southeast Asia Congenital Heart Diseases Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Congenital Heart Diseases Market Share by Application (2013-2018)
    Figure India Congenital Heart Diseases Market Size 2013-2018 (Million US$)
    Table India Key Players Congenital Heart Diseases Revenue (2017-2018) (Million US$)
    Table India Key Players Congenital Heart Diseases Market Share (2017-2018)
    Table India Congenital Heart Diseases Market Size by Type (2013-2018) (Million US$)
    Table India Congenital Heart Diseases Market Share by Type (2013-2018)
    Table India Congenital Heart Diseases Market Size by Application (2013-2018) (Million US$)
    Table India Congenital Heart Diseases Market Share by Application (2013-2018)
    Figure Central & South America Congenital Heart Diseases Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Congenital Heart Diseases Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Congenital Heart Diseases Market Share (2017-2018)
    Table Central & South America Congenital Heart Diseases Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Congenital Heart Diseases Market Share by Type (2013-2018)
    Table Central & South America Congenital Heart Diseases Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Congenital Heart Diseases Market Share by Application (2013-2018)
    Table Pfizer Company Details
    Table Pfizer Revenue in Congenital Heart Diseases Business (2013-2018) (Million US$)
    Figure Pfizer Revenue Growth Rate in Congenital Heart Diseases Business (2013-2018)
    Table Pfizer Recent Development
    Table Abbott Laboratories Company Details
    Table Abbott Laboratories Revenue in Congenital Heart Diseases Business (2013-2018)(Million US$)
    Figure Abbott Laboratories Revenue Growth Rate in Congenital Heart Diseases Business (2013-2018)
    Table Abbott Laboratories Recent Development
    Table Eli Lilly Company Details
    Table Eli Lilly Revenue in Congenital Heart Diseases Business (2013-2018)(Million US$)
    Figure Eli Lilly Revenue Growth Rate in Congenital Heart Diseases Business (2013-2018)
    Table Eli Lilly Recent Development
    Table Ranbaxy Pharmaceutical Company Details
    Table Ranbaxy Pharmaceutical Revenue in Congenital Heart Diseases Business (2013-2018)(Million US$)
    Figure Ranbaxy Pharmaceutical Revenue Growth Rate in Congenital Heart Diseases Business (2013-2018)
    Table Ranbaxy Pharmaceutical Recent Development
    Table Global Congenital Heart Diseases Market Size by Regions (Million US$) 2018-2025
    Figure Global Congenital Heart Diseases Market Size Share by Regions (2018-2025)
    Figure Global Congenital Heart Diseases Market Size Share by Regions in 2025
    Figure United States Congenital Heart Diseases Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Congenital Heart Diseases Market Size Forecast (2018-2025)(Million USD)
    Figure China Congenital Heart Diseases Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Congenital Heart Diseases Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Congenital Heart Diseases Market Size Forecast (2018-2025)(Million USD)
    Figure India Congenital Heart Diseases Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Congenital Heart Diseases Market Size Forecast (2018-2025)(Million USD)
    Table Global Congenital Heart Diseases Market Size by Product (2018-2025) (Million US$)
    Figure Global Congenital Heart Diseases Market Size by Product (2018-2025)
    Figure Global Congenital Heart Diseases Market Size by Product in 2025
    Table Global Congenital Heart Diseases Market Size by Application (2018-2025) (Million US$)
    Figure Global Congenital Heart Diseases Market Size by Application (2018-2025)
    Figure Global Congenital Heart Diseases Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Chemicals & Materials

Industrial Alliance To Help Waste Management Market To Rise

An alliance of 28 large companies has launched a global organization to find solutions to remove plastic waste from the environment. The Alliance for the Disposal of Plastic Waste (AEPW), which collaborates with the World Business Council for Sustainable Development (WBCSD), brings together chemical and plastic companies as well as consumer goods companies.

25-Feb-2019 | Electrical & Electronic Device

Insights Into Fish’s Swimming Adds Sensory Feedback Feature To Global Robotics Market

The fish have a random movement with excellent sensory feedback so as to help them navigate the world. According to the Johns Hopkins University researchers, the inclusion of this movement in understanding the active sensing behaviors of animals can actually help advance the robotic platform in terms of medical, industrial, defense, and commercial sectors. The sensors can help improve the inter ...

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...